. . . . . . . "[This review focuses on the genetic biomarker, apolipoprotein E (apoE) ?4, and on certain neuroimaging biomarkers, such as structural MRI (sMRI), fluorodeoxyglucose-positron emission tomography (FDG-PET), and PET-amyloid tracers capable of delineating the extent and distribution of amyloid-beta (A?) deposits in the brain, that can be useful in identifying cognitively normal people who are at enhanced risk of developing spAD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:18:15+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .